David Sinclair· PhD
According to recent results, NR crosses the blood-brain barrier more effectively than NMN, making it a candidate for a treatment for neurodegenerative conditions.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
According to recent results, NR crosses the blood-brain barrier more effectively than NMN, making it a candidate for a treatment for neurodegenerative conditions.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
but both form nicotinamide which can be transported into all tissue types including the brain where it can then form an ad